Alkami director granted 685 shares of stock

Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/07/2026 - 06:46 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.

ALKAMI TECHNOLOGY, INC. director Maria Ines Alvarez reported receiving an award of 685 shares of Common Stock, recorded at a price of $0.00 per share. This is a compensation-related grant, not an open-market purchase. Following the award, she holds 70,594 shares directly. The filing notes she elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan.

Insider Trade Summary

Grant/Award: 685 shares

Grant/Award 1 txn

Insider Alvarez Maria Ines

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	685	$0.00	$0.00

Holdings After Transaction: Common Stock — 70,594 shares (Direct)

Holdings Before and After: Common Stock, 69,909 to 70,594 shares (Direct)

Footnotes (1)

1. F1. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan.

Key Figures

Shares granted: 685 shares Grant price: $0.00 per share Shares owned after grant: 70,594 shares +1 more

4 metrics

Shares granted 685 shares Common Stock award to director on transaction date

Grant price $0.00 per share Equity award under 2021 Incentive Award Plan

Shares owned after grant 70,594 shares Total direct Common Stock holdings after transaction

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Common Stock, 2021 Incentive Award Plan, Grant, award, or other acquisition, Form 4

4 terms

Common Stock financial

"reported receiving an award of 685 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

2021 Incentive Award Plan financial

"elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan"

Grant, award, or other acquisition financial

"transaction code description indicates a Grant, award, or other acquisition"

Form 4 regulatory

"What did ALKT director Maria Ines Alvarez report in this Form 4?"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ALKT director Maria Ines Alvarez report in this Form 4?

Maria Ines Alvarez reported a grant of 685 shares of Alkami Technology Common Stock. The shares were awarded at a price of $0.00 per share as part of equity compensation, rather than an open-market purchase.

Is the ALKT Form 4 transaction a buy or a compensation award?

The ALKT Form 4 shows a compensation-related award, not a market buy. The transaction is coded “A” for grant or award, with 685 shares of Common Stock granted at $0.00 per share to director Maria Ines Alvarez.

How many ALKT shares does Maria Ines Alvarez hold after this transaction?

After the reported grant, Maria Ines Alvarez holds 70,594 shares of Alkami Technology Common Stock directly. This total includes the newly awarded 685 shares, reflecting her updated direct ownership position as reported in the filing.

What is the significance of the $0.00 price in the ALKT Form 4?

The $0.00 price indicates the shares were granted at no cash cost to the director. This is typical for stock awards made under incentive plans, distinguishing them from open-market purchases where insiders pay the prevailing trading price.

What does it mean that Alvarez deferred receipt of ALKT shares?

The filing notes Alvarez elected to defer receipt of these shares under the 2021 Incentive Award Plan. This means the shares are awarded now but actual delivery is postponed according to the plan’s deferral rules and her election.

Does this ALKT insider transaction involve any derivative securities?

No derivative securities are reported in this ALKT Form 4. The filing only shows a non-derivative Common Stock award of 685 shares and lists no remaining derivative positions in the derivative summary section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alvarez Maria Ines

(Last) (First) (Middle)

C/O ALKAMI TECHNOLOGY, INC.

5601 GRANITE PARKWAY, SUITE 120

(Street)

PLANO TEXAS 75024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2026		A		685(1)	A	$0	70,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan.

Remarks:

	/s/ Douglas A. Linebarger, as Attorney-in-Fact for Maria Ines Alvarez	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)